Immunity claims are next on FTC’s radar, says legal expert

Immunity claims are next on FTC’s radar, says legal expert

Related tags Federal trade commission Influenza Ftc

Immunity is likely to be the next major focus for the US Federal Trade Commission (FTC) as it closes its fist over fraudulent dietary supplement products, suggests a food and drug lawyer.

The issue – which is already on the agency’s hit list – will most certainly be in the spotlight during the weeks ahead as the potential swine flu epidemic has already triggered the promotion of supplements purporting to protect against the virus, says Marc Ullman, partner at Ullman, Shapiro & Ullman.

“Any company that engages in that kind of marketing is inviting very swift and very serious enforcement action (…) I think FTC and FDA will be all over this,”​ he tells Lorraine Heller in this podcast.

Ingredient firms beware

In addition, Ullman predicts that a recent FTC clamp-down against a weight loss ingredient supplier could be heralding a change of tides.

“I suspect that this may the first in a series of cases that we see from FTC directed at ingredients suppliers.”

Related news

Show more

Related products

show more

MOROSIL:INGREDIENT OF THE YEAR

MOROSIL:INGREDIENT OF THE YEAR

Content provided by BIONAP BIOACTIVE NATURAL PRODUCTS | 07-Mar-2024 | Product Brochure

MOROSIL™ has won as Ingredient of the Year in the category Weight Management at 2023 Nutraingredient USA. MOROSIL ™ is a standardized extract derived from...

In Weight Management Go Beyond with Slendacor®

In Weight Management Go Beyond with Slendacor®

Content provided by PLT Health Solutions | 22-Feb-2024 | White Paper

Slendacor® is a synergistic, patented formulation of three standardized herbal extracts: turmeric (Curcuma longa), moringa (Moringa oleifera) and curry...

Polyphenol extracts as weight management catalysts

Polyphenol extracts as weight management catalysts

Content provided by DolCas Biotech, LLC. | 18-Jan-2024 | White Paper

Viable natural product options for "healthy weight management" in the age of Ozempic and other GLP-1 inhibitors will require targeted innovations...

Related suppliers

Follow us

Products

View more

Webinars